Patient P-02663
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
9%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S19
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Nutritional resilience+9
- GI instability-5
- Toxicity-5
- Inflammatory activity-3
- Treatment adherence-3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable62 min
improving · +5.8 vs previous 14 d
Sleep duration
Wearable6 h
stable · -0.1 vs previous 14 d
Energy level
Daily log6/10
stable · -0.1 vs previous 14 d
Steps
Wearable6,788
improving · +745 vs previous 14 d
GI burden
Companion16.8/100
improving · -1.9 vs previous 14 d
Adherence
Companion90.8 %
worsening · -4.2 vs previous 14 d
Sleep quality
Wearable32.5/100
stable · +0.4 vs previous 14 d
Glucose, CGM daily mean
CGM134 mg/dL
stable · -0.7 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 92 from the failing basin, 8 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +6.4
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -3.4 next day
Main detractors to watch
- Bacteroides fragilis elevatedhidden · steering -7.4
- Alcoholperturbation · steering -4.6
- Poor-sleep weekperturbation · steering -3
- Low-HRV stretchperturbation · steering -2.7
- Alcoholdetractor · GI +2.6 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.4supporter · 95%
- Alcohol+2.6detractor · 73%
- Simple carbohydrates-1.6no signal · 42%
- Insoluble fibre-0.8no signal · 20%
- Dietary fat load-0.5no signal · 15%
- Caffeine-0.3no signal · 15%
- Ultra-processed food+0.2no signal · 15%
- Histamine load-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↓20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 6.0 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4.3 · butyrate capacity 46/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 42 ms
- Sleep
- 6.4 h
- Steps
- 6,621
- Resting HR
- 72 bpm
Daily log: GI score 17, nutritional resilience 67, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.